Michael A. Barry, Ph.D.
Michael A. Barry, Ph.D.
Verified email at mayo.edu - Homepage
TitleCited byYear
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
MA Barry, CA Behnke, A Eastman
Biochemical pharmacology 40 (10), 2353-2362, 1990
11221990
Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by Cisplatin
CM Sorenson, MA Barry, A Eastman
JNCI: Journal of the National Cancer Institute 82 (9), 749-755, 1990
5371990
Identification of deoxyribonuclease II as an endonuclease involved in apoptosis
MA Barry, A Eastman
Archives of Biochemistry and Biophysics 300 (1), 440-450, 1993
5191993
Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage libraries
MA Barry, WJ Dower, SA Johnston
Nature medicine 2 (3), 299, 1996
4511996
Protection against mycoplasma infection using expression-library immunization
MA Barry, WC Lai, SA Johnston
Nature 377 (6550), 632, 1995
4101995
Poly (ethylenimine)‐mediated transfection: A new paradigm for gene delivery
WT Godbey, MA Barry, P Saggau, KK Wu, AG Mikos
Journal of Biomedical Materials Research: An Official Journal of The Society …, 2000
3992000
Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification
MA Barry, JE Reynolds, A Eastman
Cancer Research 53 (10), 2349-2357, 1993
3581993
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
R Cattaneo, T Miest, EV Shashkova, MA Barry
Nature Reviews Microbiology 6 (7), 529, 2008
3362008
The Origins of DNA Breaks: A Consequence of DNA Damage, DNA Repair, or Apoptosis? New Drugs
A Eastman, MA Barry
Cancer investigation 10 (3), 229-240, 1992
3221992
Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
O Kalyuzhniy, NC Di Paolo, M Silvestry, SE Hofherr, MA Barry, PL Stewart, ...
Proceedings of the National Academy of Sciences 105 (14), 5483-5488, 2008
3182008
Lentiviral vectors: basic to translational
T Sakuma, MA Barry, Y Ikeda
Biochemical Journal 443 (3), 603-618, 2012
2942012
Biological features of genetic immunization
MA Barry, SA Johnston
Vaccine 15 (8), 788-791, 1997
2761997
Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses
H Mok, DJ Palmer, P Ng, MA Barry
Molecular Therapy 11 (1), 66-79, 2005
2452005
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer
KE Adams, S Ke, S Kwon, F Liang, Z Fan, Y Lu, K Hirshi, ME Mawad, ...
Journal of biomedical optics 12 (2), 024017, 2007
2332007
Current advances and future challenges in Adenoviral vector biology and targeting
SK Campos, MA Barry
Current gene therapy 7 (3), 189-204, 2007
2282007
Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH
MA Barry, A Eastman
Biochemical and biophysical research communications 186 (2), 782-789, 1992
2221992
Interaction of trans-diamminedichloroplatinum (II) with DNA: formation of monofunctional adducts and their reaction with glutathione
A Eastman, MA Barry
Biochemistry 26 (12), 3303-3307, 1987
2141987
Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection
ME Barry, D Pinto-Gonzalez, FM Orson, GJ McKenzie, GR Petry, MA Barry
Human gene therapy 10 (15), 2461-2480, 1999
1861999
Advances and future challenges in adenoviral vector pharmacology and targeting
R Khare, C Y Chen, E A Weaver, M A Barry
Current gene therapy 11 (4), 241-258, 2011
1652011
Semaphorin III can repulse and inhibit adult sensory afferents in vivo
DL Tanelian, MA Barry, SA Johnston, T Le, GM Smith
Nature medicine 3 (12), 1398, 1997
1381997
The system can't perform the operation now. Try again later.
Articles 1–20